Peer-reviewedLicence not statedNew England Journal of Medicine
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
Related
- Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia: a multicenter real-world evaluation using the international TriNetX database
- Cefazolin versus Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Routine Serial Follow-up Blood Cultures After a Negative Result Within 48 Hours of Methicillin-susceptible Staphylococcus aureus Bacteremia: Low Yield, High Cost
- Chlorhexidine MIC distribution, efflux pump gene profiles, and genotypic characteristics among clinical methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates
- From Heart Murmur to Bone Involvement: Tricuspid Valve Endocarditis With First-Rib Osteomyelitis in a Patient With Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
BibTeX
@article{group2026cefazolin,
title = {{Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia}},
author = {The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group},
journal = {New England Journal of Medicine},
year = {2026},
month = jun,
doi = {10.1056/nejmoa2506905},
url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7619232/},
}
RIS
TY - JOUR
TI - Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
AU - The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
PY - 2026
DA - 2026/06/17
JO - New England Journal of Medicine
DO - 10.1056/nejmoa2506905
UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC7619232/
SN - 0028-4793
SN - 0096-6762
SN - 1533-4406
SN - 2331-4710
ER -